Apures Co (XKRX:149300) Research & Development : ₩1,333.3 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Apures Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Apures Co's Research & Development for the six months ended in Dec. 2023 was ₩1,333.3 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was ₩1,333.3 Mil.

Apures Co Research & Development Historical Data

The historical data trend for Apures Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apures Co Research & Development Chart

Apures Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

1,737.83

2,146.20

2,561.90

1,905.54

1,333.29

Apures Co Semi-Annual Data
	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Research & Development	Get a 7-Day Free Trial					1,737.83	2,146.20	2,561.90	1,905.54	1,333.29

Apures Co Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was ₩1,333.3 Mil.

Apures Co (XKRX:149300) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Apures Co Research & Development Related Terms

Thank you for viewing the detailed overview of Apures Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Apures Co (XKRX:149300) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Apures Co Ltd (XKRX:149300) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

44, Hansan-gil, Cheongbuk-eup, Gyeonggi-do, Pyeongtaek-si, KOR, 17792

Website

http://www.apures.com

Apures Co Ltd is a South Korea based company engaged in the development of transgenic animals to support bio heterogeneous long-term commercialization and new drug efficacy research. It has focused its research capabilities on developing transgenic mini pigs based on gene editing technology and somatic cell nuclear transfer technology.

Apures Co (XKRX:149300) Headlines

No Headlines